Malignant transformation of recurrent respiratory papillomatosis associated with integrated human papillomavirus type 11 DNA and mutation of p53

Laryngoscope

Volumn 108, Issue 5, 1998, Pages 735-740

  Rady, Peter L ^a   Schnadig, Vicki J ^a   Weiss, Raymond L ^a   Hughes, Thomas K ^a   Tyring, Stephen K ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; PROTEIN P53;

ADULT; ARTICLE; CASE REPORT; GENETIC STABILITY; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPH NODE METASTASIS; MALE; MALIGNANT TRANSFORMATION; MOLECULAR GENETICS; PAPILLOMATOSIS; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SQUAMOUS CELL CARCINOMA; TUMOR SUPPRESSOR GENE; VIRUS MUTATION; VIRUS TYPING;

ADULT; BRONCHIAL NEOPLASMS; CARCINOMA, SQUAMOUS CELL; CELL TRANSFORMATION, NEOPLASTIC; DNA, VIRAL; GENES, P16; GENES, P53; HUMANS; LARYNGEAL NEOPLASMS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MUTATION; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; PAPILLOMA; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RESPIRATORY TRACT NEOPLASMS; TUMOR VIRUS INFECTIONS;

EID: 0031948363     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005537-199805000-00021     Document Type: Article

References (50)

1. Fechner RE, Goepfert H, Alford BR. Invasive laryngeal papillomatosis. Arch Otolaryngol 1974;99:147-51.
2. Schnadig VJ, Clark WD, Clegg TJ, et al. Invasive papillomatosis and squamous carcinoma complicating juvenile laryngeal papillomatosis. Arch Otolaryngol Head Neck Surg 1986;112:966-71.
3. Franzmann MB, Buchwald C, Larsen P, et al. Tracheobronchial involvement of laryngeal papillomatosis at onset. J Laryngol Otol 1994;108:164-5.
4. Mounts P, Shah KV, Kashima H. Viral etiology of juvenile- and adult-onset squamous papilloma of the larynx. Proc Natl Acad Sci U S A 1982;79:5425-9.
5. Terry RM, Lewis PA, Griffiths S, et al. Demonstration of human papillomavirus types 6 and 11 in juvenile laryngeal papillomatosis by in-situ DNA hybridization. J Pathol 1987;153:245-8.
6. Lindeberg H, Syrjanen S, Karja J, et al. Human papillomavirus type 11 DNA in squamous cell carcinomas and preexisting multiple laryngeal papillomas. Acta Otolaryngol (Stockh) 1989;107:141-9.
7. Steinberg BM. Human papillomaviruses and upper airway oncogenesis. Am J Otolaryngol 1990;11:370-4.
8. Dickens P, Srivastava G, Loke SL, et al. Human papillomavirus 6, 11, and 16 in laryngeal papillomas. J Pathol 1991;165:243-6..
9. Cripe TP. Human papillomaviruses: pediatric perspectives on a family of multifaceted tumorigenic pathogens. Pediatr Infect Dis J 1990;9:836-44..
10. Simma B, Burger R, Uehlinger J, et al. Squamous-cell carcinoma arising in a non-irradiated child with recurrent respiratory papillomatosis. Eur J Pediatr 1993;152:776-8.
11. Quan M-B, Moy RL. The role of human papillomavirus in carcinoma. J Am Acad Dermatol 1991;25:698-705..
12. Lie ES, Engh V, Boysen M, et al. Squamous cell carcinoma of the respiratory tract following laryngeal papillomatosis. Acta Otolaryngol (Stockh) 1994;114:209-12.
13. Keim RJ. Malignant change of laryngeal papillomas: a case report. Otolaryngol Head Neck Surg 1980;88:773-7.
14. Bewtra C, Krishnan R, Lee SS. Malignant changes in nonirradiated juvenile laryngotracheal papillomatosis. Arch Otolaryngol 1982;108:114-6.
15. Byrne JC., Ming-Sound T, Fraser RS, et al. Human papillomavirus-11 DNA in a patient with chronic laryngotracheobronchial papillomatosis and metastatic squamous-cell carcinoma of the lung. N Engl J Med 1987;317:873-8.
16. Rady P, Schnadig V, Arany I, et al. Concomitant occurrence of integrated HPV-11 and p53 mutations in squamous lung lesions in patient with juvenile laryngeal papillomatosis. 12th International Papillomavirus Conference. Baltimore, MD, Sept 26-Oct 1, 1993.
17. zur Hausen H. Viruses in human cancers. Science 1991;254: 1167-73.
18. Weinberg RA. The molecular basis of oncogenes and tumor suppressor genes. Ann N Y Acad Sci 1995;758:331-8.
19. Levine AJ, Wu MC, Chang A, et al. The spectrum of mutations at the p53 locus. Evidence for tissue-specific mutagenesis, selection of mutant alleles, and a "gain of function" phenotype. Ann N Y Acad Sci 1995;768:111-28.
20. Greenblatt MS, Bennett WP, Hollstein M, et al. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 1994;54: 4855-78.
21. Olopade OI, Buchhagen DL, Malik K, et al. Homozygous loss of the interferon genes defines the critical region on 9p that is deleted in lung cancers. Cancer Res 1993;53: 2410-5.
22. Merlo A, Gabrielson E, Askin F, et al. Frequent loss of chromosome 9 in human primary non-small cell lung cancer. Cancer Res 1994;54:640-2.
23. Scinicariello F, Rady P, Saltzstein D, et al. Human papillomavirus 16 exhibits a similar integration pattern in primary squamous cell carcinoma of the penis and in its metastasis. Cancer 1992;70:2143-8.
24. Evers BM, Rady PL, Tyring SK, et al. Amplification of the HER-2/neu protooncogene in human endocrine tumors. Surgery 1992;112:211-7.
25. Rady P. Scinicariello F. Wagner RF Jr. et al. p53 mutations in basal cell carcinomas. Cancer Res 1992;52:3804-6.
26. Kamb A, Gruis NA, Weaver-Feldhaus J, et al. A cell cycle regulator potentially involved in genesis of many tumor types. Science 1994;264:436-40.
27. Riggin CH Jr, Pitha PM. Methylation and a polymorphic restriction site adjacent to human beta-interferon gene. DNA 1982;1:267-71.
28. Barbacid M. ras Genes. Ann Rev Biochem 1987;56:779-827.
29. Segatto O, King CR, Pierce JH, et al. Different structural alterations upregulate in vitro tyrosine kinase activity and transforming potency of the erbB-2 gene. Mol Cell Biol 1988;8:5570-4.
30. Manias DA, Ostrow RS, McGlennen RC, et al. Characterization of integrated human papillomavirus type 11 DNA in primary and metastatic tumors from a renal transplant recipient. Cancer Res 1989;49:2514-9.
31. Kahn T, Turazza E, Ojeda R, et al.. Integration of human papillomavirus type 6a DNA in a tonsillar carcinoma: chromosomal localization and nucleotide sequence of the genomic target region. Cancer Res 1994;54:1305-12.
32. Popescu NC, Di Paolo JA, Ambsbough SC. Integration sites of human papillomavirus 18 DNA sequences on HeLa cell chromosomes. Cytogenet Cell Genet 1987;44:58-62,.
33. Durst, M, Croce CM, Gissmann L et al. Papillomavirus sequences integrate near cellular oncogenes in some cervical carcinomas. Proc Natl Acad Sci USA 1987;84:1070-4.
34. Couturier J, Satre-Garau X, Schneider-Maunoury S et al. Integration of papillomavirus DNA near myc genes in genital carcinomas and its consequences for protooncogene expression. J Virol 1991;65:4534-8.
35. Popescu NC, Di Paolo JA. Integration of human papillomavirus 16 DNA and genomic rearrangements in immortalized human keratinocyte cell lines. Cancer Res 1990;50: 1316-23.
36. Smith PP, Friedman CL, Bryant EM, et al. Viral integration and fragile sites in human papillomavirus immortalized human keratinocyte cell lines. Genes Chromosom Cancer 1992;5:5150-7.
37. Romanczuk H, Thierry F, Howley PM. Mutational analysis of cis elements involved in E2 modulation of human papillomavirus type 16 P97 and type 18 P105 promoters. J Virol 1990;64:2849-59.
38. Dollard SC, Broker TR, Chow LT. Regulation of the human papillomavirus type 11 E6 promoter by viral and host transcription factors in primary human keratinocytes. J Virol 1993;67:1721-6.
39. Rosen M, Auborn K. Duplication of the upstream regulatory sequences increases the transformation potential of human papillomavirus type 11. Virology 1991;185:484-7.
40. Jones PA, Rideout WM, Shen J-C, et al. Methylation, mutation and cancer Bioessays 1992;14:33-6.
41. Rideout WM, Coetzee GA, Olumi AF, et al. 5-Methylcytosine as an endogenous mutagen in the human LDL receptor and p53 genes. Science 1990;249:1288-90.
42. Harris CC. p53: at the crossroads of molecular carcinogenesis and risk assessment. Science 1993;262:1980-1.
43. Cox LS, Lane DP. Tumour suppressors, kinases and clamps: how p53 regulates the cell cycle in response to DNA damage. Bioessays 1995;17:501-8.
44. Lee JM, Bernstein A. Apoptosis, cancer and the p53 tumour suppressor gene. Cancer Metastasis Rev 1995;14:149-61.
45. Havre PA, Yuan J, Hedrick L, et al. p53 inactivation by HPV16 E6 results in increased mutagenesis in human cells. Cancer Res 1995;55:4420-4.
46. Kessis TD, Connolly DC, Hedrick L, et al. Expression of HPV16 E6 or E7 increases integration of foreign DNA. Oncogene 1996;13:427-31.
47. Eeles RA, Warren W, Knee G, et al. Constitutional mutation in exon 8 of the p53 gene in a patient with multiple primary tumours: molecular and immunohistochemical findings. Oncogene 1993;8:1269-76.
48. Rodenhuis S, Slebos RJ. Clinical significance of ras oncogene activation in human lung cancer. Cancer Res 1992;52:2665S-9S.
49. Giaccone G. Oncogenes and antioncogenes in lung tumorigenesis. Chest 1996;109:130S-4S.
50. Mao L, Hruban RH, Boyle JO, et al. Detection of oncogene mutations in sputum precedes diagnosis of lung cancer. Cancer Res 1994;54:1634-7.